RecruitingNCT07587216

Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment

Sponsor

Tongji Hospital

Enrollment

800 participants

Start Date

Jan 1, 2026

Study Type

OBSERVATIONAL

Conditions

Liver Cancer (Primary and Metastatic)

Summary

This study is a prospective, observational, real-world cohort study. We aim to establish a prospective database in the Department of Hepatobiliary and Pancreatic Surgery, systematically collecting and integrating patients' full-course diagnostic and therapeutic information along with long-term outcomes. This will enable objective evaluation of prognosis and treatment efficacy in real-world clinical practice, while providing a data foundation and evidence support for subsequent optimization of clinical decision-makin

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Systemic therapy combined with locoregional interventions and a procedure called liver resection for people with liver cancer (primary and metastatic). The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREliver resection

Patients undergo liver resection for tumor.

DRUGSystemic therapy combined with locoregional interventions

Patients recieve PD-1 inhibitors combined with targeted drugs and locoregional interventions

Locations(1)

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07587216

Related Trials

Clinical Study on the Safety, Efficacy, and Exploration of Immune Mechanisms of a Combined Multimodal Tumor Therapy System for Hepatic Malignancies

NCT074593091 location

Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy

NCT074454121 location

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

NCT074106761 location

Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology

NCT073037251 location